Clinical Trials
Petosemtamab + investigator's choice in patients w/previously treated Stage IV HNSCC
Disease Type: Head and Neck
A phase 3 open-label, randomized, controlled study to evaluate the efficacy and safety of petosemtamab compared with investigator's choice monotherapy treatment in previously treated patients with incurable, metastatic/recurrent head and neck squamous cell carcinoma (MCLA-158-CL02)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville